The biotechnology companies Amgen and Adaptative Biotechnologies have announced a collaboration agreement with the aim of responding to the Covid-19 pandemic, an agreement through which both will work on the identification and development of human antibodies that can neutralize the new coronavirus and have the potential ability to prevent or treat this disease.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
